🔗 Share this article

Treasury head Rachel Reeves has revealed she is preparing "specific steps to address household expense issues" in the upcoming Budget.

In comments to media outlets, she emphasized that reducing price rises is a joint task of both the government and the Bank of England.

The UK's price growth is projected to be the most elevated among the Group of Seven advanced economies this calendar year and the following year.

Potential Energy Cost Measures

It is understood the administration could intervene to lower energy bills, such as by cutting the present 5% rate of value-added tax applied on energy.

An additional possibility is to cut some of the government charges currently included in bills.

Fiscal Limitations and Expert Expectations

The government will receive the next report from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much room there is for such measures.

The view from the majority of analysts is that Reeves will have to announce higher taxes or spending cuts in order to fulfill her voluntary debt limits.

Previously on the same day, estimates showed there was a £22 billion shortfall for the Treasury chief to address, which is at the lower end of expectations.

"There's a joint task between the central bank and the government to bear down further on some of the causes of inflation," Reeves informed the BBC in the US capital, at the annual meetings of the IMF and World Bank.

Revenue Commitments and International Concerns

While much of the focus has been on probable tax increases, the Treasury chief said the latest figures from the OBR had not changed her commitment to election pledges not to raise tax levels on income tax, sales tax or National Insurance.

She blamed an "unpredictable world" with growing geopolitical and trade concerns for the fiscal tax moves, probably to be focused on those "wealthiest."

International Trade Tensions

Referring to worries about the UK's commercial links with the Asian nation she said: "The UK's security interests invariably come first."

Last week's announcement by China to increase trade restrictions on rare earths and other resources that are crucial for advanced tech manufacturing led American leader the US President to threaten an additional 100% tariff on imports from China, increasing the possibility of an full-scale trade war between the two economic giants.

The American finance chief labeled the Chinese action "commercial pressure" and "a global supply chain control attempt."

Questioned on accepting the US offer to participate in its conflict with China, Reeves said she was "extremely troubled" by China's measures and called on the Chinese government "to avoid restrictions and restrict access."

She said the decision was "bad for the world economy and creates additional headwinds."

"In my view there are areas where we must confront Chinese policies, but there are also valuable opportunities to sell into Chinese markets, including banking sector and other sectors of the economy. We've got to maintain that balance right."

The Treasury chief also affirmed she was working with international partners "regarding our own critical minerals plan, so that we are less reliant."

Health Service Drug Pricing and Funding

The Chancellor also admitted that the price the NHS spends on medicines could go up as a consequence of ongoing negotiations with the US government and its pharmaceutical firms, in return for reduced taxes and capital.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either pausing or canceling operations in the UK, with some blaming the modest returns they are receiving.

Last month, the government science advisor said the cost the health service pays for drugs would need to increase to stop businesses and drug research funding departing from the United Kingdom.

The Chancellor told media: "It has been observed as a result of the pricing regime, that clinical trials, new drugs have not been available in the UK in the manner that they are in other EU nations."

"The objective is to make sure that patients receiving care from the National Health Service are able to receive the top life-saving medicines in the globe. And so we are looking at these issues, and... seeking to obtain additional investment into Britain."